Eudaimonia Partners’s BioCryst Pharmaceuticals BCRX Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-9,000	Closed	-$92K	–	465
2021 Q1	$92K	Sell	9,000 -13,000	-59%	-$133K	0.02%	493
2020 Q4	$164K	Sell	22,000 -58,600	-73%	-$437K	0.04%	342
2020 Q3	$277K	Buy	+80,600	New	+$277K	0.07%	242